Barriers and facilitators to accessing opioid agonist therapy for street-involved adolescents and young adults in Vancouver
Gallant K, Nijjar P, DeBeck K, Cui M, Kerr T, J Addict Med
Topic
Harm
Reduction
Publications
Harm
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study
Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D., Harm Reduct J. 2025
Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain
Kitchen C, Socías ME, Sayre EC, Hayashi K, DeBeck K, Milloy MJ, Kerr T, Reddon H, Drug Alcohol Rev
How Do We Move the Needle on Needle Debris? A Qualitative Interview Study With Reflexive Thematic Analysis, From SANDS (Strategies for Addressing Needle Debris Study)
Jackson, J; Ainsley, E; Perry, S; Gadimova, F; Ens, T; Cameron, T; Francisco, R; Hon, A; Kim, Y; McGill, E; Patel, T; Sodhi, S; Yu, J; Ginn, C., The Canadian Journal of Addiction
Including Families in a Response to the Unregulated Toxic Drug Crisis: A Call to Action
Mathias H, Auger S, Schulz P, Hyshka E., Subst Use Misuse.
Implementation of harm reduction services for people who use drugs provided by pharmacy staff: a scoping review protocol
Navarrete J, Hughes C, Kung JY, Salokangas E, Taylor M, Hyshka E., BMJ Open
A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States
Zolopa C, Clifasefi SL, Dobischok S, Gala N, Fraser-Purdy H, Phillips MK, Blackmore S, Wendt DC, Drug Alcohol Depend. 2025
Differences in overdose rates by gender at supervised consumption services: an explanatory sequential mixed methods study
Muel, E., Fan, E., Ginn, C., & Jackson, J., Drugs: Education, Prevention and Policy
Expanding supervised consumption services in rural Canada: Bridging gaps
Mirza, N., Mathias, H., Hyshka, E., Can J Public Health
Role of Pharmacists in Addiction Medicine in Canada’s Publicly Funded Health Care Systems: A Qualitative Study
Weibe, A., Pecson, R., Coupland, M., Halpape, K., Can J Hospital Pharm.
Rural community-based participatory research with families of people who use drugs: key considerations from a multi-provincial research partnership.
Mathias, H., Duff, E., Schulz, P. et al., Harm Reduct J.
Responding to drug-related harm among South Asian populations in Canada
Mirza, N., Singh, M. & Hyshka, E., Can J Public Health
A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing
Côté J, Auger P, Chicoine G, Cheng J, Cossette S, Fontaine G, Genest C, Lal S, Lapierre J, Pagé MG, Maheu-Cadotte MA, Rouleau G, Vinette B, Jutras-Aswad D., JMIR Form Res. 2025
The erosion of safer supply programs in Ontario, Canada: A dangerous step backward
Ali, F., Sprakes, A., Mende-Gibson, J., Russell,C., Shaw, A., Bonn, M., Celinski, A., Kaminski, N., Karamouzian, M., Strike, C., Rhem, J., Drug Science, Policy and Law
Physician perspectives on reducing harm and supporting emergency department patients who use drugs
Zoe K. D. Collins,Elaine Hyshka,Karine J. Lavergne,Savannah M. Weber,Ginetta Salvalaggio,Cindy Jiaxin Xue,Arlanna Pugh,Janusz Kaczorowski,Aaron M. Orkin,Andrew Kestler,Kathryn A. Dong, PLoS One
Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial survey
Ali, F. , Russell,C., Law, J., Imtiaz, S., Budau, J., Shahin, R., MacKinnon, L., Griffith, S., Patenaude, S., Xavier, J., Rhem, J., Harm Reduction Journal
Indigenous peoples and medications for opioid use disorders: A scoping review
Gala N, Dobischok S, Bernett P, Parker DG, O’Callahan A, Zentner D, Huson K, Tomaro J, Wendt DC., Psychol Addict Behav. 2025
Exploring unregulated substance use health data in Ontario, Canada: Identifying gaps, addressing challenges, and uncovering opportunities
Ali, F., Law, J., Russell, C., Imtiaz, S., Bayoumi, A., Werb, D., Rhem, J., Front. Public Health
Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l’urine et l’usage autodéclaré dans le contexte d’un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l’usage d’opioïdes vendus sur ordonnance
Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D., Can J Psychiatry. 2025
Impacts of the COVID-19 Pandemic on Opioid Use Disorder and Services for American Indian and Alaska Native Communities
Parker DG, Radin S, Sorlagas N, Wendt DC., Health Res. 2025
Harnessing telemedicine to deliver patient‑centered opioid agonist treatment within a community‑based harm reduction service: a mixed methods evaluation
Stine Bordier Høj, Rémi Coignard‑Friedman, Aissata Sako, Catherine de Montigny, Marie‑Ève Beauchemin‑Nadeau, Robert Léandre, Nanor Minoyan, Geneviève Boyer‑Legault, Sofiane Chougar, Sara‑Kim Lamont, Julie Bruneau, Harm Reduction Journal , 2025
Engagement with and acceptability of telephone-based telemedicine in addiction care in Vancouver, Canada, 2020–2023
Hayashi K, Reading D, Bach P, Choi JC, Hedden L, Milloy MJ, DeBeck K, J Addict Med
A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Uyen Do, Sarah Larney, Matthew Bonn, Ingrid Matei, Camille Zolopa, Amy Bergeron, Mohammad Karamouzian, Elaine Hyshka, Thomas D. Brothers, Nikki Bozinoff, Dan Werb, Didier Jutras‑Aswad, Stine Høj, Isabelle Boisvert, Igor Yakovenko, Julie Bruneau, International Journal of Drug Policy, 2025
Policing and access to harm reduction services among young people who use drugs and young Indigenous people who use drugs before and after the pilot implementation of decriminalization of personal possession
McAdam E, Milloy MJ, Sayre EC, Verdicchio C, Sedgemore K, May H, Pranteau S, Corriveau D, Friesen D, Fleury M, Fast D, DeBeck K, Int J Drug Policy READ MORE
Longitudinal polysubstance use patterns and non-fatal overdose: a repeated measures latent class analysis
Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T, Int J Drug Policy
A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis
Coronado-Montoya S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, Côté J, Crocker CE, Crockford D, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lachance-Touchette P, Lecomte T, L’Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D., Psychiatry Res. 2025
